Zhongzhu Healthcare Holding Co Ltd (600568:SHH) is a China-based holding company principally engaged in pharmaceutical manufacturing, medical services, medical devices, and real estate development. The company operates through four main segments: the Real Estate Development segment, which focuses on real estate development and sales; the Medical segment, which provides hospital operations and medical services; the Financial Leasing segment, which conducts related financial leasing business; and the Pharmaceutical and Others segment, which encompasses medical device and pharmaceutical manufacturing, including ophthalmology drugs, hepatest ultrasonic liver cirrhosis detectors, infusion heaters, and Luna God full-body gamma knives. Zhongzhu Healthcare Holding Co Ltd primarily serves the domestic Chinese market, with operations centered in Zhuhai, and was founded in 1970 (incorporated in 1994) with headquarters located at Special No. 1 Zhanghua South Road, Zhuhai, Guangdong Province, China. In recent developments, the company completed the acquisition of the remaining 38.41% stake in its subsidiary Hengqin Zhongzhu Financial Leasing Co., Ltd. from Zhang Yusa, strengthening its financial leasing operations, while it cancelled a proposed acquisition of ZhuHai NewiKou Science & Technology Co., Ltd. from Zhuhai Zhongzhu Group Co., Ltd. The company changed its name to Zhongzhu Healthcare Holding Co., Ltd. in June 2016 to reflect its diversified healthcare and real estate focus.